IL22RA2 and intestinal neoplasm: Furthermore, Il22ra2 expression in intestinal tumors or IL-22BP expression in myeloid cells was suppressed by PGE2 treatment both in vivo and in vitro (Fig. 6c, d; Supplementary Fig. 5e, f), suggesting that IL-22BP production is negatively regulated by PGE2.